Wire · regulatory
FDA issues final PDUFA meeting guidance, expands use of written responses
◆ Sectors
Biotech
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 19 August 2026 · Fusion42 review
The FDA finalized updated guidance for PDUFA meetings with sponsors, narrowing the use of INTERACT meetings and expanding use of written responses instead of live meetings for several meeting types, while adding clarity to meeting request requirements.
This Wire brief sits within Fusion42's coverage of Biotech.
◆ ◆ The Wire takeaway
You face tighter rules around early FDA meetings and more written-only responses that reduce interaction. Adjust your regulatory plans to address less direct FDA engagement and prepare clearer meeting requests.
◆ Coverage
1 source · 19 Aug 2026
◆ Related on Wire
◆ Topics
Biotechfdapdufaregulatory-guidancedrug-developmentindustry